The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis

The safety of antiplatelet therapy in haemodialysis (HD) patients remains controversial. we conducted the first meta-analysis to evaluate the bleeding risk with antiplatelet agents in these populations.
Source: BMC Nephrology - Category: Urology & Nephrology Authors: Tags: Research article Source Type: research